Nexavar

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
34	神経線維腫症	2

34. 神経線維腫症

臨床試験数 : 133 / 薬物数 : 186 - (DrugBank : 67) / 標的遺伝子数 : 79 - 標的パスウェイ数 : 190

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2011-001789-16-GB (EUCTR)	26/08/2011	17/05/2011	Investigation of the intra-tumoural concentration and activity of sorafenib in cutaneous schwannomas ...	Investigation of the intra-tumoural concentration and activity of sorafenib in cutaneous schwannomas ...	Neurofibromatosis, type 2 (acoustic neurofibromatosis) MedDRA version: 14.0;Level: LLT;Classificatio ...	Trade Name: Nexavar INN or Proposed INN: sorafenib (as tosylate) Other descriptive name: Nexavar	Plymouth Hospital NHS Trust	NULL	Not Recruiting			Female: yes Male: yes	14	Phase 4	United Kingdom
2	NCT00727233 (ClinicalTrials.gov)	July 8, 2008	31/7/2008	Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform ...	Phase I Trial of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, Nexav ...	Neurofibromatosis Type I;Plexiform Neurofibroma	Drug: Nexavar(BAY 43-9006) (Sorafenib);Drug: Toxicity, Pharmacokinetics;Drug: Pharmacodynamics;Drug: ...	National Cancer Institute (NCI)	NULL	Completed	3 Years	18 Years	All	9	Phase 1	United States

First Previous1Next Last